These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25752765)

  • 21. A growth and latency compromised herpes simplex virus type 2 mutant (ICP10DeltaPK) has prophylactic and therapeutic protective activity in guinea pigs.
    Wachsman M; Kulka M; Smith CC; Aurelian L
    Vaccine; 2001 Feb; 19(15-16):1879-90. PubMed ID: 11228357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses.
    Blevins TP; Mitchell MC; Korom M; Wang H; Yu Y; Morrison LA; Belshe RB
    PLoS One; 2015; 10(12):e0144738. PubMed ID: 26658766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of microbicides for efficacy in protecting mice against vaginal challenge with herpes simplex virus type 2, cytotoxicity, antibacterial properties, and sperm immobilization.
    Maguire RA; Bergman N; Phillips DM
    Sex Transm Dis; 2001 May; 28(5):259-65. PubMed ID: 11354263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inactivation of HSV-1 and HSV-2 and prevention of cell-to-cell virus spread by Santolina insularis essential oil.
    De Logu A; Loy G; Pellerano ML; Bonsignore L; Schivo ML
    Antiviral Res; 2000 Dec; 48(3):177-85. PubMed ID: 11164504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-type calcium channels blockers inhibit HSV-2 infection at the late stage of genome replication.
    Ding L; Jiang P; Xu X; Lu W; Yang C; Li L; Zhou P; Liu S
    Eur J Pharmacol; 2021 Feb; 892():173782. PubMed ID: 33279521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action.
    Ceña-Diez R; Vacas-Córdoba E; García-Broncano P; de la Mata FJ; Gómez R; Maly M; Muñoz-Fernández MÁ
    Int J Nanomedicine; 2016; 11():2147-62. PubMed ID: 27274240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of six cell lines in the suspension-infection test used for the detection of herpes simplex virus.
    Rich T; Johnson FB
    Diagn Microbiol Infect Dis; 1998 Oct; 32(2):81-4. PubMed ID: 9823529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity of two synthetic amphiphilic peptides and magainin-2 against herpes simplex virus types 1 and 2.
    Aboudy Y; Mendelson E; Shalit I; Bessalle R; Fridkin M
    Int J Pept Protein Res; 1994 Jun; 43(6):573-82. PubMed ID: 7928088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2.
    Zhao X; Deak E; Soderberg K; Linehan M; Spezzano D; Zhu J; Knipe DM; Iwasaki A
    J Exp Med; 2003 Jan; 197(2):153-62. PubMed ID: 12538655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitive and rapid detection of herpes simplex virus and varicella-zoster virus DNA by loop-mediated isothermal amplification.
    Kaneko H; Iida T; Aoki K; Ohno S; Suzutani T
    J Clin Microbiol; 2005 Jul; 43(7):3290-6. PubMed ID: 16000450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential responses of murine vaginal and uterine epithelial cells prior to and following herpes simplex virus type 2 (HSV-2) infection.
    Fernandez S; Gillgrass A; Kaushic C
    Am J Reprod Immunol; 2007 May; 57(5):367-77. PubMed ID: 17430501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis of acyclovir-resistant herpes simplex type 2 isolates in animal models of genital herpes: models for antiviral evaluations.
    Bernstein DI; Ireland J; Bourne N
    Antiviral Res; 2000 Sep; 47(3):159-69. PubMed ID: 10974368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital disease.
    Da Costa XJ; Bourne N; Stanberry LR; Knipe DM
    Virology; 1997 May; 232(1):1-12. PubMed ID: 9185583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of herpes simplex virus type 2 (HSV-2) viral replication by the dominant negative mutant polypeptide of HSV-1 origin binding protein.
    Yao F; Eriksson E
    Antiviral Res; 2002 Feb; 53(2):127-33. PubMed ID: 11750938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of DNA immunization formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus infection.
    Bernstein DI; Tepe ER; Mester JC; Arnold RL; Stanberry LR; Higgins T
    Vaccine; 1999 Apr; 17(15-16):1964-9. PubMed ID: 10217595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro inactivation of herpes simplex virus by a biological response modifier, PSK.
    Monma Y; Kawana T; Shimizu F
    Antiviral Res; 1997 Aug; 35(3):131-8. PubMed ID: 9298752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immunomodulator, ammonium trichloro[1,2-ethanediolato-O,O']-tellurate, suppresses the propagation of herpes simplex virus 2 by reducing the infectivity of the virus progeny.
    Sheinboim D; Hindiyeh M; Mendelson E; Albeck M; Sredni B; Dovrat S
    Int J Mol Med; 2015 Jul; 36(1):231-8. PubMed ID: 25936393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunity to vaginal infection by herpes simplex virus type 2 in adult mice: characterization of the immunoglobulins in vaginal mucus.
    Parr EL; Bozzola JJ; Parr MB
    J Reprod Immunol; 1998 Apr; 38(1):15-30. PubMed ID: 9616875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune responses and protection against vaginal infection after nasal or vaginal immunization with attenuated herpes simplex virus type-2.
    Parr EL; Parr MB
    Immunology; 1999 Dec; 98(4):639-45. PubMed ID: 10594699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of a Combretum micranthum extract against herpes simplex virus types 1 and 2.
    Ferrea G; Canessa A; Sampietro F; Cruciani M; Romussi G; Bassetti D
    Antiviral Res; 1993 Aug; 21(4):317-25. PubMed ID: 8215303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.